Arthrex has received U.S. Food and Drug Administration (FDA) clearance for its NanoScope operative arthroscopy system for pediatric orthopedics and laparoscopy.

NanoScope is a compact, high-resolution mobile imaging platform featuring the NanoNeedle Scope, a high-definition, chip-on-tip camera. This was engineered specifically to meet the anatomical and procedural needs of pediatric patients.

The system can be used in common pediatric cases like general knee arthroscopy, meniscal treatments, anterior cruciate ligament (ACL) reconstruction, general shoulder arthroscopy and hernia or diagnostic laparoscopy in the abdomen. The smaller scope helps minimize possible risk of damaging anatomical structures upon entry along with neurovascular structures.

“This innovative and disruptive technology is transforming the way we approach diagnostic and least-invasive surgical treatments, and we are extremely proud to expand its indications to the field of pediatric orthopedics and laparoscopy,” said Arthrex President and Founder Reinhold Schmieding.

“FDA clearance for use of the NanoScope system in pediatric patients is an important, exciting step forward,” added J. Lee Pace, MD. “Its smaller size makes it ideal for navigating pediatric joints while still delivering excellent image quality for routine or even more complex cases.”

Last month, the company launched Synergy Power, a versatile and reliable battery-powered system designed for various orthopedic applications.